Omniscan and Osteomyelitis - a phase IV clinical study of FDA data

Summary:

Osteomyelitis is reported as a side effect among people who take Omniscan (gadodiamide), especially for people who are male, 50-59 old, have been taking the drug for < 1 month also take Optimark, and have Nuclear magnetic resonance imaging brain.

The phase IV clinical study analyzes which people have Osteomyelitis when taking Omniscan. It is created by eHealthMe based on reports of 6,166 people who have side effects when taking Omniscan from the FDA, and is updated regularly.

What is Omniscan?

Omniscan has active ingredients of gadodiamide. eHealthMe is studying from 6,169 Omniscan users. Check the latest studies of Omniscan.

What is Osteomyelitis?

Osteomyelitis (infection of bone) is found to be associated with 1,428 drugs and 1,327 conditions by eHealthMe. Check the latest studies of Osteomyelitis.

On Jul, 12, 2026

6,166 people reported to have side effects when taking Omniscan.
Among them, 22 people (0.36%) have Osteomyelitis.

Among these 22 people:

How long have people been on Omniscan when they have Osteomyelitis? *

What is the gender of people who have Osteomyelitis when taking Omniscan? *

female: 40.91 %
male: 59.09 %

What is the age of people who have Osteomyelitis when taking Omniscan? *

What are other drugs people take besides Omniscan? *

What are other side effects people have besides Osteomyelitis? *

Nephrogenic Systemic Fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease): 18 people, 81.82%
Intervertebral Discitis (infection in the intervertebral disc space): 10 people, 45.45%
Staphylococcal Bacteraemia (a bacterial infection of blood): 8 people, 36.36%
Pneumonia: 8 people, 36.36%
Depression: 7 people, 31.82%
Back Pain: 6 people, 27.27%
Fall: 6 people, 27.27%
Skin Ulcer: 6 people, 27.27%
Spinal Osteoarthritis (joint cartilage loss in spine): 5 people, 22.73%
Diarrhea: 5 people, 22.73%

What are the existing conditions these people have? *

Nuclear Magnetic Resonance Imaging Brain: 10 people, 45.45%
Nuclear Magnetic Resonance Imaging Abdominal: 5 people, 22.73%
Productive Cough: 4 people, 18.18%
Osteoporosis (bones weak and more likely to break): 4 people, 18.18%
Intervertebral Discitis (infection in the intervertebral disc space): 4 people, 18.18%
Ankylosing Spondylitis (type of arthritis affecting the spine): 4 people, 18.18%
Diabetes: 1 person, 4.55%
Anaemia (lack of blood): 1 person, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Omniscan and have Osteomyelitis?

- Check whether Osteomyelitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Omniscan:

Omniscan (6,169 reports)

Osteomyelitis treatments and more:

Osteomyelitis (34,172 reports)

Browse all side effects of Omniscan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Osteomyelitis:

Osteomyelitis (1,428 drugs)

Browse all the conditions that are associated with Osteomyelitis:

Osteomyelitis (1,327 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on gadodiamide (the active ingredients of Omniscan) and Omniscan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.